Key statistics
On Friday, Glaukos Corp (GKOS:NYQ) closed at 120.40, -7.55% below its 52-week high of 130.23, set on Jan 22, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 119.69 |
|---|---|
| High | 121.03 |
| Low | 118.43 |
| Bid | 93.05 |
| Offer | 140.00 |
| Previous close | 121.43 |
| Average volume | 880.10k |
|---|---|
| Shares outstanding | 58.08m |
| Free float | 55.78m |
| P/E (TTM) | -- |
| Market cap | 6.99bn USD |
| EPS (TTM) | -3.27 USD |
Data delayed at least 15 minutes, as of Feb 27 2026 21:00 GMT.
More ▼
- Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
- Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR
- Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
- Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
- Glaukos Announces Participation in J.P. Morgan Healthcare Conference
More ▼
